Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up study of metformin therapy in children and adolescents with neurogenic or neuromuscular disorders
2009-009278-29Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in insulin resistance (IR), obesity, muscle diseases (NMD) and 1 more, sponsored by UZ Leuven. Primary endpoint: insulin resistance. Started Jan 2009; status: completed.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)obesitymuscle diseases (NMD)neurological diseases
Beyond the preview
Go deeper on 2009-009278-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009278-29.